Pharmaust Ltd - ESG Rating & Company Profile powered by AI
The ESG score covers 17 United Nations SDGs including: 'Zero Hunger', 'Reduced Inequalities' and 'Partnerships for the Goals'. This ESG assessment for Pharmaust Ltd represents its reporting of the UN Sustainable Development Goals. This webpage of Pharmaust Ltd is prepared by All Street Sevva using proprietary Cognitive Robots.
Pharmaust Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 0.0, social score of 5.3 and governance score of 2.7.
2.7
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1393 | Vaccinex Inc | 2.8 | Medium |
1393 | YSP Southeast Asia Holding Bhd | 2.8 | Medium |
1437 | Pharmaust Ltd | 2.7 | Medium |
1437 | CanadaBis Capital Inc | 2.7 | Medium |
1437 | Cannabics Pharmaceuticals Inc | 2.7 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Pharmaust Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Pharmaust Ltd disclose current and historical energy intensity?
Does Pharmaust Ltd report the average age of the workforce?
Does Pharmaust Ltd reference operational or capital allocation in relation to climate change?
Does Pharmaust Ltd disclose its ethnicity pay gap?
Does Pharmaust Ltd disclose cybersecurity risks?
Does Pharmaust Ltd offer flexible work?
Does Pharmaust Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Pharmaust Ltd disclose the number of employees in R&D functions?
Does Pharmaust Ltd conduct supply chain audits?
Does Pharmaust Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Pharmaust Ltd conduct 360 degree staff reviews?
Does Pharmaust Ltd disclose the individual responsible for D&I?
Does Pharmaust Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Pharmaust Ltd disclose current and / or historical scope 2 emissions?
Does Pharmaust Ltd disclose water use targets?
Does Pharmaust Ltd have careers partnerships with academic institutions?
Did Pharmaust Ltd have a product recall in the last two years?
Does Pharmaust Ltd disclose incidents of discrimination?
Does Pharmaust Ltd allow for Work Councils/Collective Agreements to be formed?
Has Pharmaust Ltd issued a profit warning in the past 24 months?
Does Pharmaust Ltd disclose parental leave metrics?
Does Pharmaust Ltd disclose climate scenario or pathway analysis?
Does Pharmaust Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Pharmaust Ltd disclose the pay ratio of women to men?
Does Pharmaust Ltd support suppliers with sustainability related research and development?
Does Pharmaust Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Pharmaust Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Pharmaust Ltd involved in embryonic stem cell research?
Does Pharmaust Ltd disclose GHG and Air Emissions intensity?
Does Pharmaust Ltd disclose its waste policy?
Does Pharmaust Ltd report according to TCFD requirements?
Does Pharmaust Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Pharmaust Ltd disclose energy use targets?
Does Pharmaust Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Pharmaust Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Pharmaust Ltd
These potential risks are based on the size, segment and geographies of the company.
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.